| Source Date | Board Meeting Date | Details |
|
08-May-2026
|
15-May-2026
|
Final Dividend & Audited Results
|
|
19-Jan-2026
|
28-Jan-2026
|
Quarterly Results & Interim Dividend
|
|
29-Oct-2025
|
06-Nov-2025
|
Quarterly Results & Interim Dividend
|
|
24-Jul-2025
|
01-Aug-2025
|
Quarterly Results & Interim Dividend
|
|
30-Apr-2025
|
07-May-2025
|
Final Dividend & Audited Results
|
|
08-Apr-2025
|
12-Apr-2025
|
Inter alia, to consider and approve:- 1. The Company considers divesting its shareholding / monetizing its stake in the following subsidiaries: a. Symphony AU Pty Limited, Australia, and b. IMPCO S de R.I. de C.V., Mexico (IMPCO). Board Actions required: 1. Grant an In-principle approval and authorise management to initiate the proceedings for the divestment/monetization of stakes in the aforementioned subsidiaries. 2. Consider and approve the appointment of and terms ofreferences for Investment Banker(s) to initiate and facilitate this process. 3. Authorize management to re-classify investment in thesesubsidiaries as ?Assets held for Sale? in the Balance Sheet starting from the date of enabling board resolution. 4. To Consider and approve the sale of technology and Intellectual Property Rights (IPRs) by Guangdong Symphony Keruilai Air Coolers Co. Ltd., China (GSK) to IMPCO at ~ USD 5.1 million (equivalent toapproximately ? 43.5 crores) and authorise GSK to use sales proceeds amount (net of costs, taxes etc.) to repay loan to Symphony Limited,India. 3. The Board will review various initiatives undertaken by the Companyin the realm of Environmental, Social and Governance (ESG).
|
|
29-Jan-2025
|
05-Feb-2025
|
Quarterly Results & Interim Dividend
|
|
21-Oct-2024
|
29-Oct-2024
|
Quarterly Results & Interim Dividend
|
|
22-Jul-2024
|
06-Aug-2024
|
Quarterly Results & Interim Dividend & Buy Back of Shares
|
|
22-Apr-2024
|
30-Apr-2024
|
Final Dividend & Audited Results
|
